<DOC>
	<DOCNO>NCT00817830</DOCNO>
	<brief_summary>The purpose study assess safety lodenafil carbonate patient coronaropathy , evaluate response body face physical effort , include heart respiratory component , without use lodenafil carbonate 80mg .</brief_summary>
	<brief_title>Cardiovascular Safety Study Lodenafil Carbonate Patients With Coronaropathy During Physical Effort</brief_title>
	<detailed_description>Phosphodiesterase 5 inhibitor ( iPDE5 ) effective drug treat erectile dysfunction ( ED ) . ED link several factor , like advanced age diabetes predominant incidence . In addition , ED early manifestation cardiovascular disease . Among iPDE5 exist Brazilian market new molecule call lodenafil carbonate . It recently approve release use Brazil , similar effectiveness adverse reaction compare drug family . The molecule evaluate respect possible change heart rate , blood pressure QT interval , result point excellent cardiovascular safety profile . There corelated incidence patient coronary artery disease erectile dysfunction . Although patient stable angina , appropriate clinical treatment show increase cardiovascular risk sexual intercourse , increase incidence erectile dysfunction population determine specific group patient high potential use iPDE5 . Therefore essential new phosphodiesterase 5 inhibitor evaluate patient coronary artery disease , especially heart rate , physical effort .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Coronary artery disease obstruction &lt; 70 % , confirm prior catheterization , stable patient , already show acute event ( unstable angina myocardial infarction , accord guideline Brazilian Society Cardiology ) least 6 month ; Age ≥ 18 ≤ 60 ; Men ; Stable 6 month , regardless previous myocardial infarction revascularization ; ejection fraction doppler echocardiography ≥ 50 % . Use nitrate ; Use bronchodilator ; Smoking current period le 6 month ; Hemoglobin &lt; 10 g / dL ; Systolic pressure &gt; 160 mm Hg &lt; 100 mmHg ; Diastolic pressure &gt; 110 mm Hg &lt; 60 mmHg ; Body mass index ( BMI ) &gt; 30 ; Symptomatic peripheral artery disease ; Event angina AMI , time , whether I 've do examination ; Finger tip blood glucose &lt; 70 &gt; 200mg/dL time examination ; Chest injury &gt; 50 % ; Triple arterial injury surgery indication ; Moderate severe chronic obstructive pulmonary disease ( COPD ) confirm spirometry ; Pulmonary hypertension pressure &gt; 35mmHg confirmed doppler echocardiography ; Moderate important aortic and/or mitral valvulopathy confirm doppler echocardiography ; Changes enzyme marker ( Troponin I ) first test ;</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Coronaropathy</keyword>
	<keyword>lodenafil carbonate</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Treatment</keyword>
	<keyword>QT interval</keyword>
	<keyword>Phosphodiesterase inhibitor</keyword>
	<keyword>Cardiac arrhythmia</keyword>
	<keyword>Effort testPhosphodiesterase 5 inhibitor</keyword>
	<keyword>Cardiovascular test</keyword>
</DOC>